Here we investigated the impact of pharmacological antagonism of C/EBPβ with lucicebtide on human peripheral blood mononuclear cell (hPBMC)-derived macrophage cultures in vitro and on TAMs in syngeneic mouse tumor models in vivo. This evidence concerns the gene CEBPB and neoplasm.